EP Patent

EP1044967A2 — 2-Pyridinylguanidine urokinase inhibitors

Assigned to Pfizer Ltd Great Britain · Expires 2000-10-18 · 26y expired

What this patent protects

Compounds of formula (I) :- or a pharmaceutically acceptable salt thereof, or solvate of either entity, wherein R 4 is a guanidinyl moiety and the other substituents are as defined in the text, are urokinase inhibitors.

USPTO Abstract

Compounds of formula (I) :- or a pharmaceutically acceptable salt thereof, or solvate of either entity, wherein R 4 is a guanidinyl moiety and the other substituents are as defined in the text, are urokinase inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP1044967A2
Jurisdiction
EP
Classification
—
Expires
2000-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Ltd Great Britain
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.